Christian Ferreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christian Ferreira has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Marcio Yuri Ferreira
Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY
2 shared publications - Raphael Bertani
Department of Neurosurgery, University of São Paulo
2 shared publications - Ahmet Günkan
Department of Radiology and Imaging Sciences, Division of Interventional Radiology, University of Arizona Medical Center, Tucson, USA
1 shared publication - David J. Langer
Department of Neurosurgery, Lenox Hill Hospital/Northwell Health
1 shared publication - Elísio Bulhões
College of Higher Education of the United Amazon, Redenção, Para, Brazil
1 shared publication - Eric Slawka
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- 22 July 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (9) , 2410-2418
Aggressive vs. Conservative Blood Pressure Reduction in Acute Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
OBJECTIVES: Intracerebral hemorrhage carries high mortality and long-term disability. The optimal blood pressure (BP) management strategy—aggressive vs. conservative lowering—remains uncertain. This review compares both strategies. DATA SOURCES: Articles from PubMed, Web of Science, Embase, and Cochrane were screened to August 2025. STUDY SELECTION: Only randomized open-label blinded-endpoint trials were included. DATA EXTRACTION: Patient characteristics, inclusion criteria, interventions, and outcomes were independently extracted by two authors; conflicts were resolved by a third. DATA SYNTHESIS: Eight randomized controlled trials (12,669 patients; median age 63 yr; 60% male) met inclusion. No significant differences emerged between aggressive and conservative strategies for excellent functional outcome (risk ratio [RR], 1.07; 95% CI, 0.99–1.16; p = 0.94; I 2 = 33%), good functional outcome (RR, 1.09; 95% CI, 0.99–1.20; p = 0.07; I 2 = 51%), 90-day mortality (RR, 0.90; 95% CI, 0.77–1.05; p = 0.18; I 2 = 0%), or hematoma growth (RR, 0.85; 95% CI, 0.66–1.10; p = 0.22; I 2 = 48%). Aggressive BP lowering was associated with fewer adverse events (RR, 0.87; 95% CI, 0.76–0.99; p = 0.03; I 2 = 59%). Sensitivity analyses showed significant benefits of the aggressive approach for good recovery (RR, 1.05; 95% CI, 1.01–1.10; p = 0.02; I 2 = 0%), although not confirmed in the subgroup analyses (RR, 1.09; 95% CI, 0.97–1.23; p = 0.14; I 2 = 61%). For adverse events, subgroup analyses consistently favored the aggressive strategy (RR, 0.81; 95% CI, 0.74–0.88; p < 0.01; I 2 = 0%). No clear association with hematoma growth emerged, largely due to heterogeneity. CONCLUSIONS: Aggressive and conservative BP lowering yielded similar outcomes for functional recovery, mortality, and hematoma growth. Aggressive BP lowering was linked to fewer adverse events, with some subgroup analyses suggesting modest functional benefits.
- 22 July 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (9) , 2410-2418
Aggressive vs. Conservative Blood Pressure Reduction in Acute Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
OBJECTIVES: Intracerebral hemorrhage carries high mortality and long-term disability. The optimal blood pressure (BP) management strategy—aggressive vs. conservative lowering—remains uncertain. This review compares both strategies. DATA SOURCES: Articles from PubMed, Web of Science, Embase, and Cochrane were screened to August 2025. STUDY SELECTION: Only randomized open-label blinded-endpoint trials were included. DATA EXTRACTION: Patient characteristics, inclusion criteria, interventions, and outcomes were independently extracted by two authors; conflicts were resolved by a third. DATA SYNTHESIS: Eight randomized controlled trials (12,669 patients; median age 63 yr; 60% male) met inclusion. No significant differences emerged between aggressive and conservative strategies for excellent functional outcome (risk ratio [RR], 1.07; 95% CI, 0.99–1.16; p = 0.94; I 2 = 33%), good functional outcome (RR, 1.09; 95% CI, 0.99–1.20; p = 0.07; I 2 = 51%), 90-day mortality (RR, 0.90; 95% CI, 0.77–1.05; p = 0.18; I 2 = 0%), or hematoma growth (RR, 0.85; 95% CI, 0.66–1.10; p = 0.22; I 2 = 48%). Aggressive BP lowering was associated with fewer adverse events (RR, 0.87; 95% CI, 0.76–0.99; p = 0.03; I 2 = 59%). Sensitivity analyses showed significant benefits of the aggressive approach for good recovery (RR, 1.05; 95% CI, 1.01–1.10; p = 0.02; I 2 = 0%), although not confirmed in the subgroup analyses (RR, 1.09; 95% CI, 0.97–1.23; p = 0.14; I 2 = 61%). For adverse events, subgroup analyses consistently favored the aggressive strategy (RR, 0.81; 95% CI, 0.74–0.88; p < 0.01; I 2 = 0%). No clear association with hematoma growth emerged, largely due to heterogeneity. CONCLUSIONS: Aggressive and conservative BP lowering yielded similar outcomes for functional recovery, mortality, and hematoma growth. Aggressive BP lowering was linked to fewer adverse events, with some subgroup analyses suggesting modest functional benefits.
- 17 June 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (8) , 1669-1681
Diagnostic accuracy of ultrasonographic optic nerve sheath diameter compared to invasive ICP monitoring for intracranial hypertension in pediatric patients
Background Monitoring intracranial pressure (ICP) is essential in pediatric neurocritical care, but invasive methods pose risks, highlighting the need for accurate non-invasive alternatives like ultrasonographic optic nerve sheath diameter (ONSD) measurement. Objective To evaluate the diagnostic accuracy of ultrasonographic measurement of the ONSD for detecting elevated ICP in children, stratified by age (< 1 year or > 1 year). Materials and methods A systematic search was conducted in PubMed, Embase, and Cochrane from inception to February 3, 2025. Eligible studies included prospective or retrospective cohorts and randomized trials comparing ultrasonographic ONSD with invasive ICP measurements (mmHg) in pediatric patients, reporting data for a 2 × 2 table. The analyses included (1) sensitivity; (2) specificity; (3) summary receiver operating characteristic curve; (4) area under the curve; (5) diagnostic odds ratio; and (6) likelihood ratios. A random-effects model was used, with 95% confidence intervals and subgroup differences assessed (P < 0.05 statistically significant). Results Seven studies with 380 patients were included. ONSD cutoffs ranged from 4.0 mm to 5.29 mm across studies. For the 20 mmHg cutoff (n = 369), sensitivity was 91.6% [95% CI, 83.2–96.0] and specificity was 71.9% [95% CI, 65.4–77.6]. For the 15 mmHg cutoff (n = 304), sensitivity was 89.3% [95% CI, 83.9–93.1] and specificity was 76.2% [95% CI, 68.0–82.8]. Sensitivity differences by age were statistically significant at 20 mmHg (P = 0.03), with 245 patients > 1 year (sensitivity, 90.1% [95% CI, 83.3–94.3]) and 124 patients < 1 year (sensitivity, 75.7% [95% CI, 59.5–86.8]). Conclusion The diagnostic accuracy of ultrasound-measured ONSD in detecting intracranial hypertension was high in pediatric patients, although sensitivity varied with age. These findings highlight the importance of age-stratified analyses to assess ONSD accuracy, particularly in infants. Graphical Abstract
- 17 June 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (8) , 1669-1681
Diagnostic accuracy of ultrasonographic optic nerve sheath diameter compared to invasive ICP monitoring for intracranial hypertension in pediatric patients
Background Monitoring intracranial pressure (ICP) is essential in pediatric neurocritical care, but invasive methods pose risks, highlighting the need for accurate non-invasive alternatives like ultrasonographic optic nerve sheath diameter (ONSD) measurement. Objective To evaluate the diagnostic accuracy of ultrasonographic measurement of the ONSD for detecting elevated ICP in children, stratified by age (< 1 year or > 1 year). Materials and methods A systematic search was conducted in PubMed, Embase, and Cochrane from inception to February 3, 2025. Eligible studies included prospective or retrospective cohorts and randomized trials comparing ultrasonographic ONSD with invasive ICP measurements (mmHg) in pediatric patients, reporting data for a 2 × 2 table. The analyses included (1) sensitivity; (2) specificity; (3) summary receiver operating characteristic curve; (4) area under the curve; (5) diagnostic odds ratio; and (6) likelihood ratios. A random-effects model was used, with 95% confidence intervals and subgroup differences assessed (P < 0.05 statistically significant). Results Seven studies with 380 patients were included. ONSD cutoffs ranged from 4.0 mm to 5.29 mm across studies. For the 20 mmHg cutoff (n = 369), sensitivity was 91.6% [95% CI, 83.2–96.0] and specificity was 71.9% [95% CI, 65.4–77.6]. For the 15 mmHg cutoff (n = 304), sensitivity was 89.3% [95% CI, 83.9–93.1] and specificity was 76.2% [95% CI, 68.0–82.8]. Sensitivity differences by age were statistically significant at 20 mmHg (P = 0.03), with 245 patients > 1 year (sensitivity, 90.1% [95% CI, 83.3–94.3]) and 124 patients < 1 year (sensitivity, 75.7% [95% CI, 59.5–86.8]). Conclusion The diagnostic accuracy of ultrasound-measured ONSD in detecting intracranial hypertension was high in pediatric patients, although sensitivity varied with age. These findings highlight the importance of age-stratified analyses to assess ONSD accuracy, particularly in infants. Graphical Abstract
- Open Access
- 2 January 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108180
P2Y12 inhibitors plus aspirin versus aspirin alone in patients with ischemic cerebrovascular events: An updated meta-analysis of randomized controlled trials
- 2 January 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108180
Open AccessP2Y12 inhibitors plus aspirin versus aspirin alone in patients with ischemic cerebrovascular events: An updated meta-analysis of randomized controlled trials